
Mario Balsa/X
Jun 2, 2025, 09:10
Mario Balsa: POLCA-GB at ASCO25
Mario Balsa, Medical Oncology resident at ICO, posted on X:
“POLCA-GB at ASCO25
Preop chemoradiation (CRT) doubles median OS vs chemo alone in locally advanced GB: mOS: 21.8 vs 10.1 mo (HR 0.53, p=0.003)
5-yr OS: 28.9% vs 17%
EFS, PFS and ORR all improved
Preop CRT: ready for primetime in GBC? From signal to standard.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 00:35
Jun 3, 2025, 16:39